WO2021170053A1 - 25-hydroxyvitamin d analysis method based on immunopurification in combination with mass spectrometric detection - Google Patents

25-hydroxyvitamin d analysis method based on immunopurification in combination with mass spectrometric detection Download PDF

Info

Publication number
WO2021170053A1
WO2021170053A1 PCT/CN2021/077973 CN2021077973W WO2021170053A1 WO 2021170053 A1 WO2021170053 A1 WO 2021170053A1 CN 2021077973 W CN2021077973 W CN 2021077973W WO 2021170053 A1 WO2021170053 A1 WO 2021170053A1
Authority
WO
WIPO (PCT)
Prior art keywords
hydroxyvitamin
analysis method
antibody
biotin
magnetic beads
Prior art date
Application number
PCT/CN2021/077973
Other languages
French (fr)
Chinese (zh)
Inventor
姜宽
祝长城
许海峰
Original Assignee
苏州新波生物技术有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 苏州新波生物技术有限公司 filed Critical 苏州新波生物技术有限公司
Publication of WO2021170053A1 publication Critical patent/WO2021170053A1/en

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • G01N30/08Preparation using an enricher
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • G01N30/14Preparation by elimination of some components
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • G01N2030/067Preparation by reaction, e.g. derivatising the sample

Definitions

  • the invention relates to the technical field of biological detection, in particular to a 25-hydroxyvitamin D analysis method based on immunopurification combined with mass spectrometry detection.
  • 25-hydroxyvitamin D includes 25-hydroxyvitamin D2 (25-(OH)D2) and 25-hydroxyvitamin D3 (25-(OH)D3), which is the main presence of vitamin D in the body form.
  • the level of serum 25-(OH)D can reflect the body's vitamin D storage level, and is related to the clinical symptoms of vitamin D deficiency.
  • the detection methods of 25-(OH)D2 and 25-(OH)D3 in biological samples mainly include liquid chromatography mass spectrometry and immunoassay.
  • 25-(OH)D2 and 25-(OH)D3 need to be enriched and separated from biological samples.
  • Traditional sample processing methods mainly include precipitation, liquid-liquid extraction and solid-phase extraction.
  • the substances in the obtained samples are separated by liquid chromatography according to their different properties and then analyzed by mass spectrometry according to the different mass-nucleus ratios.
  • Liquid chromatography mass spectrometry can realize the simultaneous detection of 25-(OH)D2 and 25-(OH)D3.
  • the enriched samples contain 25-(OH)D2 and 25-(OH)D3. It also contains a large amount of matrix materials with properties similar to 25-(OH)D.
  • chromatographic separation some non-target analytes are prone to denaturation and precipitation on the chromatographic column or difficult to elute from the chromatographic column, resulting in higher matrix effects, causing column pressure to rise, and affecting the effectiveness of subsequent separation and analysis of target substances Performance and stability, increase the difficulty and burden of liquid mass spectrometry maintenance.
  • chromatography to completely separate the target analyte from its isomers or structural analogs is extremely difficult and time-consuming. Incompletely separated matrix materials may also interfere with the mass spectrometric quantification of the analyte.
  • Immunoassay analysis methods include radioimmunoassay (RIA), enzyme-linked immunoassay (ELISA), chemiluminescence immunoassay (CLIA), electrochemiluminescence immunoassay (ECLIA) and fully automated biochemical methods.
  • the basic principle is to use 25-(OH)D antibodies to specifically capture 25-(OH)D in biological samples, and then detect the corresponding radiation, light or electrochemical signals to achieve the analysis of 25-(OH)D Purpose.
  • 25-(OH)D2 and 25-(OH)D3 will be captured by antibodies, so the immunoassay method detects the total 25-(OH)D level, and it is also vulnerable to other 25-(OH)D structures. Cross interference of similar analytes affects quantification and limits clinical applications.
  • the present invention intends to provide a 25-hydroxyvitamin D analysis method that can accurately detect 25-(OH)D2 and 25-(OH)D3, respectively, and has high specificity.
  • the present invention provides a 25-hydroxyvitamin D analysis method based on immunopurification combined with mass spectrometry detection.
  • the present invention provides a 25-hydroxyvitamin D analysis method based on immunopurification combined with mass spectrometry detection, which includes the following steps:
  • Step two prepare magnetic beads coated with biotin-labeled antibody:
  • Step three enrich and purify the sample: add the sample to the isotope internal standard solution, the magnetic beads coated with the biotin-labeled antibody, stir and incubate at room temperature, and repeat the washing with ultrapure water for at least 3 times; the washed magnetic beads use an organic solvent Perform two elutions and collect the eluate;
  • Step four mass spectrometry detection: the eluent obtained in step three is dried and reconstituted or directly transferred to a microplate, and tested by a liquid-phase mass spectrometer.
  • step one is performed at 4°C or room temperature for 16-24 hours.
  • the temperature of the thermostat in step one is set to 25 ⁇ 1°C.
  • the weight ratio of antibody and biotin in step one is 10-20:1.
  • the preparation method of the magnetic bead cleaning solution in step two is: at room temperature, add 1.212g of Tris, 9.0g of sodium chloride, 0.4mL of HCl, 0.2mL of Tween-20, to a certain volume of purified water. 5.0mL of 20% NaN 3, 0.5mL of Brij-35, pH of the mixed detection 8.3 ⁇ 0.2 qualified, purified water volume to 1L.
  • the method for preparing the binding buffer in step two is: add 6.06 g of Tris, 9.0 g of sodium chloride and 3.84 mL of HCl to a certain volume of purified water at room temperature, stir for at least 5 minutes until it is completely dissolved, and then add 1.0mL of Tween-20 and 5mL of 20% NaN 3 , and finally slowly add 10.0g of bovine serum albumin (BSA), and stir for at least 10 minutes to completely dissolve; after all the ingredients are completely dissolved, use a pH meter to measure the pH at 7.2 ⁇ 0.1 is qualified, and the volume of purified water is set to 1L.
  • BSA bovine serum albumin
  • the volume ratio of the magnetic beads to the magnetic bead cleaning solution is less than or equal to 1:2.
  • isotope internal standard solution is 2 H 3 -25-hydroxy vitamin D2 or 2 H 3 -25-hydroxy vitamin D3.
  • step three the incubation conditions in step three are: room temperature, 30 min.
  • the organic phase used for elution in step 3 is 75% acetonitrile, which contains 0.1% formic acid.
  • the parameters of the shaking reaction in step 3 are: reacting for 16-24 hours at a temperature of 37 ⁇ 2° C. and an shaking speed of 100 rpm/min.
  • the present invention adopts the above technical solutions and has the following technical effects:
  • the invention relates to a 25-hydroxyvitamin D analysis method based on immunopurification combined with mass spectrometry detection, which utilizes the high specificity of antibody affinity, and can specifically enrich and purify 25-(OH)D from complex biological samples, and simultaneously achieve The precise detection of 25-(OH)D2 and 25-(OH)D3 respectively; antibody-coupled magnetic bead enrichment method combined with mass spectrometry detection achieves high-throughput, sensitive and accurate quantification while greatly improving the liquid-phase mass spectrometry system The efficiency of use.
  • the invention can be used to develop small molecule detection and diagnostic kits, a combination of multiple antibody-coupled magnetic beads, which can simultaneously enrich and detect multiple biomarkers by mass spectrometry at one time. Compared with the traditional immunoassay single-index detection, the throughput Higher, more specific and selective.
  • FIG. 1 is an operation flowchart of an analysis method in an embodiment of the present invention
  • 1 is antibody-coupled magnetic beads; 2 is the enrichment and purification of markers; 3 is the multi-index and Suzuki-specific detection of mass spectrometry.
  • the present invention provides a 25-hydroxyvitamin D analysis method based on immunopurification combined with mass spectrometry detection.
  • the present invention will be described in detail and concretely through specific examples below, so as to better understand the present invention, but the following examples do not It does not limit the scope of the present invention.
  • this embodiment provides a 25-hydroxyvitamin D analysis method based on immunopurification combined with mass spectrometry detection, which includes the following steps:
  • Step two prepare magnetic beads coated with biotin-labeled antibody:
  • Step three enrich and purify the sample: take 100 ⁇ L of serum, add 100 ⁇ L of internal standard solution (containing 2 H 3 -25-hydroxyvitamin D2 (20ng/mL), 2 H 3 -25-hydroxyvitamin D3 (20ng/mL)), 300 ⁇ L antibody magnetic beads, incubate with stirring at room temperature for 30min, transfer the magnetic beads to 500 ⁇ L ultrapure water, stir and mix, and repeat washing at least 3 times. The washed magnetic beads were transferred to 100 ⁇ L of 75% acetonitrile (containing 0.1% formic acid), mixed well for 5 minutes, and collected the eluate. The magnetic beads were washed once again, and the eluates were collected twice.
  • internal standard solution containing 2 H 3 -25-hydroxyvitamin D2 (20ng/mL), 2 H 3 -25-hydroxyvitamin D3 (20ng/mL)
  • 300 ⁇ L antibody magnetic beads incubate with stirring at room temperature for 30min, transfer the magnetic beads to 500 ⁇ L ultrapure water, stir and mix, and repeat washing at least 3
  • Step 4 Mass spectrometry detection: The eluent can be dried, reconstituted with an appropriate solvent, or directly transferred 150 ⁇ L to a 96-well microtiter plate, and tested by a liquid-phase mass spectrometer.
  • the preparation method of the magnetic bead cleaning solution in step two is: at room temperature, add 1.212g of Tris, 9.0g of sodium chloride, 0.4mL of HCl, 0.2mL of Tween-20, 5.0 to a certain volume of purified water mL of 20% NaN 3 , 0.5 mL of Brij-35, after mixing uniformly, the pH value is 8.3 ⁇ 0.2, it is qualified, and the volume of purified water is adjusted to 1L.
  • the method for preparing the binding buffer in step two is: add 6.06g of Tris, 9.0g of sodium chloride and 3.84mL of HCl to a certain volume of purified water at room temperature, stir for at least 5min until completely dissolved, and then add 1.0mL Tween-20 and 5mL 20% NaN 3 , and finally slowly add 10.0g bovine serum albumin (BSA), stirring at least 10 minutes to completely dissolve; after all the ingredients are completely dissolved, use a pH meter to measure the pH value at 7.2 ⁇ 0.1 Qualified, the volume of purified water is set to 1L.
  • BSA bovine serum albumin
  • This comparative example uses traditional liquid chromatography mass spectrometry to detect and analyze 25-hydroxyvitamin D. The results are shown in Table 4-6 below:
  • the method provided by the present invention can specifically enrich and purify 25-(OH)D from complex biological samples, while simultaneously achieving precise detection of 25-(OH)D2 and 25-(OH)D3, respectively. Compared with traditional methods, it has the characteristics of high specificity, high throughput and accurate quantification.

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

A 25-hydroxyvitamin D (25-(OH)D) analysis method based on immunopurification in combination with mass spectrometric detection, mainly comprising the following steps: preparing a biotin-labelled antibody; preparing a magnetic bead that is coated with the biotin-labelled antibody; enriching and purifying a sample; and performing mass spectrometric detection. In the analysis method, by using a high specificity of antibody affinity, 25-(OH)D can be specifically enriched and purified from complex biological samples, and the accurate detection of 25-(OH)D2 and 25-(OH)D3 is separately achieved; according to an antibody-coupled magnetic bead enrichment method in combination with mass spectrometric detection, the use efficiency of a liquid phase mass spectrometry system is greatly improved while high throughput, sensitivity, and accurate quantification are achieved.

Description

一种基于免疫纯化结合质谱检测的25-羟维生素D分析方法An analytical method of 25-hydroxyvitamin D based on immunopurification combined with mass spectrometry detection 技术领域Technical field
本发明涉及生物检测技术领域,尤其涉及一种基于免疫纯化结合质谱检测的25-羟维生素D分析方法。The invention relates to the technical field of biological detection, in particular to a 25-hydroxyvitamin D analysis method based on immunopurification combined with mass spectrometry detection.
背景技术Background technique
25-羟维生素D(25-(OH)D)包括25-羟维生素D2(25-(OH)D2)和25-羟维生素D3(25-(OH)D3),是维生素D在体内的主要存在形式。血清25-(OH)D的高低可以反映人体维生素D的储存水平,并且与维生素D缺乏的临床症状是相关的。生物样本(如全血、血清、尿液或唾液)中的25-(OH)D2和25-(OH)D3检测方法主要包括液相色谱质谱法和免疫分析法。25-hydroxyvitamin D (25-(OH)D) includes 25-hydroxyvitamin D2 (25-(OH)D2) and 25-hydroxyvitamin D3 (25-(OH)D3), which is the main presence of vitamin D in the body form. The level of serum 25-(OH)D can reflect the body's vitamin D storage level, and is related to the clinical symptoms of vitamin D deficiency. The detection methods of 25-(OH)D2 and 25-(OH)D3 in biological samples (such as whole blood, serum, urine or saliva) mainly include liquid chromatography mass spectrometry and immunoassay.
液相色谱质谱法检测前,25-(OH)D2和25-(OH)D3需从生物样本中富集和分离出来,传统的样本处理方法主要包括沉淀法,液液萃取法和固相萃取法,获得样本中的物质根据性质不同经液相色谱分离随后根据质核比不同经质谱检测分析。液相色谱质谱法可实现25-(OH)D2和25-(OH)D3的同时检测。Before detection by liquid chromatography mass spectrometry, 25-(OH)D2 and 25-(OH)D3 need to be enriched and separated from biological samples. Traditional sample processing methods mainly include precipitation, liquid-liquid extraction and solid-phase extraction. According to the method, the substances in the obtained samples are separated by liquid chromatography according to their different properties and then analyzed by mass spectrometry according to the different mass-nucleus ratios. Liquid chromatography mass spectrometry can realize the simultaneous detection of 25-(OH)D2 and 25-(OH)D3.
但是,液相色谱质谱法的样本的前处理均为非特异性富集方法,富集的样本成分较为复杂,富集出的样本中除含有25-(OH)D2和25-(OH)D3外还包含大量与25-(OH)D性质相似的基质物质。在色谱分离时,一些非目标分析物物质易在色谱柱上发生变性沉淀或难以从色谱柱上洗脱,造成较高的基质效应,引起柱压升高,影响后续目标物质的分离分析的有效性和稳定性,增加液相质谱维护的难度和负担。使用色谱将目标分析物和其同分异构体或结构类似物完全分离的难度极大同时十分耗时,未完全分离的基质物质还可能会干扰分析物的质谱定量。However, the pre-treatment of liquid chromatography-mass spectrometry samples are all non-specific enrichment methods, and the components of the enriched samples are more complicated. The enriched samples contain 25-(OH)D2 and 25-(OH)D3. It also contains a large amount of matrix materials with properties similar to 25-(OH)D. During chromatographic separation, some non-target analytes are prone to denaturation and precipitation on the chromatographic column or difficult to elute from the chromatographic column, resulting in higher matrix effects, causing column pressure to rise, and affecting the effectiveness of subsequent separation and analysis of target substances Performance and stability, increase the difficulty and burden of liquid mass spectrometry maintenance. Using chromatography to completely separate the target analyte from its isomers or structural analogs is extremely difficult and time-consuming. Incompletely separated matrix materials may also interfere with the mass spectrometric quantification of the analyte.
免疫法分析法包括放射免疫法(RIA)、酶联免疫法(ELISA)、化学发光免疫法(CLIA)、电化学发光免疫法(ECLIA)和全自动生化法。其基本原理是利用25-(OH)D的抗体特异地捕获生物样本中的25-(OH)D,然后通过检测相应的放射量、光或电化学信号,达到分析25-(OH)D的目的。但一般25- (OH)D2和25-(OH)D3均会被抗体捕获,因而免疫分析法检测的为总25-(OH)D的水平,同时也易受其他25-(OH)D结构相似分析物的交叉干扰,影响定量和限制临床应用。Immunoassay analysis methods include radioimmunoassay (RIA), enzyme-linked immunoassay (ELISA), chemiluminescence immunoassay (CLIA), electrochemiluminescence immunoassay (ECLIA) and fully automated biochemical methods. The basic principle is to use 25-(OH)D antibodies to specifically capture 25-(OH)D in biological samples, and then detect the corresponding radiation, light or electrochemical signals to achieve the analysis of 25-(OH)D Purpose. But generally 25-(OH)D2 and 25-(OH)D3 will be captured by antibodies, so the immunoassay method detects the total 25-(OH)D level, and it is also vulnerable to other 25-(OH)D structures. Cross interference of similar analytes affects quantification and limits clinical applications.
因此,本发明拟提供一种能分别精准检测25-(OH)D2和25-(OH)D 3,并且特异性高的25-羟维生素D分析方法。Therefore, the present invention intends to provide a 25-hydroxyvitamin D analysis method that can accurately detect 25-(OH)D2 and 25-(OH)D3, respectively, and has high specificity.
发明内容Summary of the invention
本发明针对现有技术的不足,提供了一种基于免疫纯化结合质谱检测的25-羟维生素D分析方法。Aiming at the deficiencies of the prior art, the present invention provides a 25-hydroxyvitamin D analysis method based on immunopurification combined with mass spectrometry detection.
为实现上述目的,本发明采用以下技术方案:In order to achieve the above objectives, the present invention adopts the following technical solutions:
本发明提供了一种基于免疫纯化结合质谱检测的25-羟维生素D分析方法,包括如下步骤:The present invention provides a 25-hydroxyvitamin D analysis method based on immunopurification combined with mass spectrometry detection, which includes the following steps:
步骤一,制备生物素标记抗体:Step one, prepare biotin-labeled antibody:
(1)用pH为8.1的磷酸盐缓冲液透析25-(OH)D抗体16-24h,将透析后的抗体加入生物素,然后进一步加入磷酸盐缓冲液对抗体进行稀释,并混匀得到混合液;(1) Dialyze the 25-(OH)D antibody with pH 8.1 phosphate buffer solution for 16-24 hours, add the dialyzed antibody to biotin, and then further add phosphate buffer solution to dilute the antibody, and mix to obtain a mixture liquid;
(2)将混合液置于恒温培养箱中,静置反应120±10min得到生物素标记抗体;(2) Place the mixed solution in a constant temperature incubator and let it stand for 120±10 minutes to obtain a biotin-labeled antibody;
(3)使用pH为7.4的磷酸盐缓冲液透析生物素化抗体16-24h;(3) Dialysis the biotinylated antibody with phosphate buffer at pH 7.4 for 16-24 hours;
步骤二,制备生物素标记抗体包被的磁珠:Step two, prepare magnetic beads coated with biotin-labeled antibody:
(1)将亲和素磁珠用磁珠清洗液清洗,然后再用结合缓冲液复溶;(1) Wash the avidin magnetic beads with magnetic bead cleaning solution, and then reconstitute it with binding buffer;
(2)将溶解后的亲和素磁珠和步骤一制备的所述生物素标记抗体混合,然后置于恒温振荡箱振荡反应得到生物素标记抗体包被的磁珠;(2) Mix the dissolved avidin magnetic beads with the biotin-labeled antibody prepared in step 1, and then place the biotin-labeled antibody in a constant temperature shaking box to oscillate to obtain biotin-labeled antibody-coated magnetic beads;
(3)反应后,用磁珠清洗液清洗所述磁珠,并稀释,2-8℃保存待用;(3) After the reaction, wash the magnetic beads with a magnetic bead cleaning solution, dilute, and store at 2-8°C until use;
步骤三,富集纯化样品:将样品加入同位素内标溶液、所述生物素标记抗体包被的磁珠,室温搅拌孵育,用超纯水重复洗涤至少3次;洗涤后的磁珠采用有机溶剂进行2次洗脱,并收集洗脱液;Step three, enrich and purify the sample: add the sample to the isotope internal standard solution, the magnetic beads coated with the biotin-labeled antibody, stir and incubate at room temperature, and repeat the washing with ultrapure water for at least 3 times; the washed magnetic beads use an organic solvent Perform two elutions and collect the eluate;
步骤四,质谱检测:步骤三得到的洗脱液吹干后复溶或直接转移至微孔板中,上液相质谱仪器检测。Step four, mass spectrometry detection: the eluent obtained in step three is dried and reconstituted or directly transferred to a microplate, and tested by a liquid-phase mass spectrometer.
进一步地,步骤一中透析是在4℃或室温条件下进行的,持续16-24h。Further, the dialysis in step one is performed at 4°C or room temperature for 16-24 hours.
进一步地,步骤一中的恒温箱的温度设置为25±1℃。Further, the temperature of the thermostat in step one is set to 25±1°C.
进一步地,步骤一中抗体和生物素的重量比为10-20:1。Further, the weight ratio of antibody and biotin in step one is 10-20:1.
进一步地,步骤二中磁珠清洗液的配制方法为:室温条件下,向一定体积的纯化水中加入1.212g的Tris、9.0g的氯化钠、0.4mL的HCl、0.2mL的Tween-20、5.0mL的20%NaN 3、0.5mL的Brij-35,混合均匀后检测pH值为8.3±0.2为合格,纯化水定容至1L。 Further, the preparation method of the magnetic bead cleaning solution in step two is: at room temperature, add 1.212g of Tris, 9.0g of sodium chloride, 0.4mL of HCl, 0.2mL of Tween-20, to a certain volume of purified water. 5.0mL of 20% NaN 3, 0.5mL of Brij-35, pH of the mixed detection 8.3 ± 0.2 qualified, purified water volume to 1L.
进一步,步骤二中结合缓冲液的配制方法为:室温条件下,向一定体积的纯化水中加入6.06g的Tris、9.0g的氯化钠和3.84mL的HCl,至少搅拌5min至完全溶解,然后加入1.0mL的Tween-20和5mL 20%NaN 3,最后缓慢加入10.0g的牛血清白蛋白(BSA),至少搅拌10min至完全溶解;待所有成分完全溶解后,用pH计测pH值在7.2±0.1为合格,纯化水定容至1L。 Further, the method for preparing the binding buffer in step two is: add 6.06 g of Tris, 9.0 g of sodium chloride and 3.84 mL of HCl to a certain volume of purified water at room temperature, stir for at least 5 minutes until it is completely dissolved, and then add 1.0mL of Tween-20 and 5mL of 20% NaN 3 , and finally slowly add 10.0g of bovine serum albumin (BSA), and stir for at least 10 minutes to completely dissolve; after all the ingredients are completely dissolved, use a pH meter to measure the pH at 7.2± 0.1 is qualified, and the volume of purified water is set to 1L.
进一步地,步骤二清洗时,磁珠与磁珠清洗液的体积比小于或等于1:2。Further, during the cleaning step 2, the volume ratio of the magnetic beads to the magnetic bead cleaning solution is less than or equal to 1:2.
进一步地,同位素内标溶液为 2H 3-25-羟基维生素D2或 2H 3-25-羟基维生素D3。 Further, the isotope internal standard solution is 2 H 3 -25-hydroxy vitamin D2 or 2 H 3 -25-hydroxy vitamin D3.
进一步地,步骤三中孵育的条件为:室温,30min。Further, the incubation conditions in step three are: room temperature, 30 min.
进一步地,步骤三中洗脱采用的有机相为75%乙腈,其含0.1%甲酸。Further, the organic phase used for elution in step 3 is 75% acetonitrile, which contains 0.1% formic acid.
进一步地,步骤三中的振荡反应的参数为:在温度为37±2℃,振荡速度为100rmp/min的条件下反应16-24h。Further, the parameters of the shaking reaction in step 3 are: reacting for 16-24 hours at a temperature of 37±2° C. and an shaking speed of 100 rpm/min.
本发明采用以上技术方案,与现有技术相比,具有如下技术效果:Compared with the prior art, the present invention adopts the above technical solutions and has the following technical effects:
本发明涉及一种基于免疫纯化结合质谱检测的25-羟维生素D分析方法利用抗体亲和的高特异性,可以将25-(OH)D特异地从复杂生物样本中富集并纯化,同时实现25-(OH)D2和25-(OH)D3的分别精准检测;抗体偶联磁珠富集法结合质谱检测在实现高通量、灵敏和准确定量的同时,极大地提升了液相质谱系统的使用效率。此外,利用该发明可开发小分子检测和诊断试剂盒,多种抗体偶联磁珠组合,可一次同时富集并质谱检测多种生物标志物,相对于传统的免疫法单指标检测,通量更高,特异性和选择性更强。The invention relates to a 25-hydroxyvitamin D analysis method based on immunopurification combined with mass spectrometry detection, which utilizes the high specificity of antibody affinity, and can specifically enrich and purify 25-(OH)D from complex biological samples, and simultaneously achieve The precise detection of 25-(OH)D2 and 25-(OH)D3 respectively; antibody-coupled magnetic bead enrichment method combined with mass spectrometry detection achieves high-throughput, sensitive and accurate quantification while greatly improving the liquid-phase mass spectrometry system The efficiency of use. In addition, the invention can be used to develop small molecule detection and diagnostic kits, a combination of multiple antibody-coupled magnetic beads, which can simultaneously enrich and detect multiple biomarkers by mass spectrometry at one time. Compared with the traditional immunoassay single-index detection, the throughput Higher, more specific and selective.
附图说明Description of the drawings
图1为本发明一实施例中的分析方法的操作流程图;FIG. 1 is an operation flowchart of an analysis method in an embodiment of the present invention;
其中,1为抗体偶联磁珠;2为标记物的富集和纯化;3为质谱的多指标和铃木特异性检测。Among them, 1 is antibody-coupled magnetic beads; 2 is the enrichment and purification of markers; 3 is the multi-index and Suzuki-specific detection of mass spectrometry.
具体实施方式Detailed ways
本发明提供了一种基于免疫纯化结合质谱检测的25-羟维生素D分析方法,下面通过具体实施例对本发明进行详细和具体的介绍,以使更好的理解本发明,但是下述实施例并不限制本发明范围。The present invention provides a 25-hydroxyvitamin D analysis method based on immunopurification combined with mass spectrometry detection. The present invention will be described in detail and concretely through specific examples below, so as to better understand the present invention, but the following examples do not It does not limit the scope of the present invention.
实施例Example
参考图1,本实施例提供一种基于免疫纯化结合质谱检测的25-羟维生素D分析方法,包括如下步骤:Referring to Figure 1, this embodiment provides a 25-hydroxyvitamin D analysis method based on immunopurification combined with mass spectrometry detection, which includes the following steps:
步骤一,制备生物素标记抗体:Step one, prepare biotin-labeled antibody:
取1mg 25-(OH)D抗体,用磷酸盐缓冲液(pH 8.1)在4℃或室温透析不少于16-24h;将透析后的抗体加入0.05mg生物素,再加入磷酸盐缓冲液(pH 8.1)使抗体终浓度为1mg/mL,混匀5min;将混合液置于恒温培养箱25±1℃,静置反应120±10min,最后使用磷酸盐缓冲液(pH 7.4)于4℃或室温透析生物素化抗体16-24h。Take 1 mg of 25-(OH)D antibody and dialyze it with phosphate buffer (pH 8.1) at 4°C or room temperature for no less than 16-24 hours; add 0.05 mg of biotin to the dialyzed antibody, and then add phosphate buffer ( pH 8.1) Make the final concentration of the antibody 1mg/mL, mix for 5 minutes; place the mixture in a constant temperature incubator at 25±1°C, let stand for 120±10 minutes, and finally use phosphate buffer (pH 7.4) at 4°C or The biotinylated antibody was dialyzed at room temperature for 16-24h.
步骤二,制备生物素标记抗体包被的磁珠:Step two, prepare magnetic beads coated with biotin-labeled antibody:
把链霉亲和素磁珠摇匀,然后吸取20mg磁珠(体积xμL),用不低于两倍磁珠体积的磁珠清洗液清洗两遍,然后用结合缓冲液把磁珠复溶至不低于5mg/mL;把磁珠和上述生物素化抗体混合,磁珠终浓度不低于10mg/mL,磁珠置于恒温振荡箱37±2℃,100rmp/min摇匀反应16-24h;把反应后的磁珠取下,用不低于2倍反应体积的磁珠清洗液清洗4遍,将磁珠用结合缓冲液稀释至400μg/mL,2-8℃保存待用。Shake the streptavidin magnetic beads well, then suck 20mg magnetic beads (volume x μL), wash twice with a magnetic bead cleaning solution not less than twice the volume of the magnetic beads, and then reconstitute the magnetic beads to Not less than 5mg/mL; mix the magnetic beads with the above-mentioned biotinylated antibody, the final concentration of the magnetic beads is not less than 10mg/mL, the magnetic beads are placed in a constant temperature shaking box 37±2℃, 100rmp/min shake and react for 16-24h ; Remove the reacted magnetic beads, wash 4 times with a magnetic bead cleaning solution of not less than 2 times the reaction volume, dilute the magnetic beads to 400μg/mL with binding buffer, and store at 2-8°C until use.
步骤三,富集纯化样品:取100μL血清,加入100μL内标溶液(含 2H 3-25-羟基维生素D2(20ng/mL)、 2H 3-25-羟基维生素D3(20ng/mL))、300μL抗体磁珠,室温搅拌孵育30min,磁珠转移至500μL超纯水中,搅拌混合,重复洗涤至少3次。洗涤后的磁珠转移至100μL 75%乙腈(含0.1%甲酸)中,充分混合5min,收集洗脱液,磁珠重复洗涤一次,汇集两次洗脱液。 Step three, enrich and purify the sample: take 100μL of serum, add 100μL of internal standard solution (containing 2 H 3 -25-hydroxyvitamin D2 (20ng/mL), 2 H 3 -25-hydroxyvitamin D3 (20ng/mL)), 300μL antibody magnetic beads, incubate with stirring at room temperature for 30min, transfer the magnetic beads to 500μL ultrapure water, stir and mix, and repeat washing at least 3 times. The washed magnetic beads were transferred to 100 μL of 75% acetonitrile (containing 0.1% formic acid), mixed well for 5 minutes, and collected the eluate. The magnetic beads were washed once again, and the eluates were collected twice.
步骤四,质谱检测:洗脱液可选择吹干,用适当溶剂复溶,或直接转移150μL至96孔微孔板中,上液相质谱仪器检测。Step 4. Mass spectrometry detection: The eluent can be dried, reconstituted with an appropriate solvent, or directly transferred 150μL to a 96-well microtiter plate, and tested by a liquid-phase mass spectrometer.
其中,步骤二中磁珠清洗液的配制方法为:室温条件下,向一定体积的纯化水中加入1.212g的Tris、9.0g的氯化钠、0.4mL的HCl、0.2mL的Tween-20、5.0mL的20%NaN 3、0.5mL的Brij-35,混合均匀后检测pH值为8.3±0.2为合格,纯化水定容至1L。 Among them, the preparation method of the magnetic bead cleaning solution in step two is: at room temperature, add 1.212g of Tris, 9.0g of sodium chloride, 0.4mL of HCl, 0.2mL of Tween-20, 5.0 to a certain volume of purified water mL of 20% NaN 3 , 0.5 mL of Brij-35, after mixing uniformly, the pH value is 8.3±0.2, it is qualified, and the volume of purified water is adjusted to 1L.
步骤二中结合缓冲液的配制方法为:室温条件下,向一定体积的纯化水中加入6.06g的Tris、9.0g的氯化钠和3.84mL的HCl,至少搅拌5min至完全溶解,然后加入1.0mL的Tween-20和5mL 20%NaN 3,最后缓慢加入10.0g的牛血清白蛋白(BSA),至少搅拌10min至完全溶解;待所有成分完全溶解后,用pH计测pH值在7.2±0.1为合格,纯化水定容至1L。 The method for preparing the binding buffer in step two is: add 6.06g of Tris, 9.0g of sodium chloride and 3.84mL of HCl to a certain volume of purified water at room temperature, stir for at least 5min until completely dissolved, and then add 1.0mL Tween-20 and 5mL 20% NaN 3 , and finally slowly add 10.0g bovine serum albumin (BSA), stirring at least 10 minutes to completely dissolve; after all the ingredients are completely dissolved, use a pH meter to measure the pH value at 7.2 ± 0.1 Qualified, the volume of purified water is set to 1L.
对该评估方法的效果进行分析,得到如表1-3所示的结果。The effect of this evaluation method is analyzed, and the results shown in Table 1-3 are obtained.
表1精密度的计算结果Table 1 Calculation results of precision
Figure PCTCN2021077973-appb-000001
Figure PCTCN2021077973-appb-000001
表2线性范围的计算结果Table 2 Calculation results of linear range
Figure PCTCN2021077973-appb-000002
Figure PCTCN2021077973-appb-000002
表3 25-羟维生素D的回收率Table 3 Recovery rate of 25-hydroxyvitamin D
分析物Analyte 平均(%)average(%) 95%置信区间95% confidence interval
25-羟维生素D225-hydroxy vitamin D2 9494 88-10088-100
25-羟维生素D325-hydroxyvitamin D3 9090 79-10079-100
对比例Comparison
本对比例使用传统液相色谱质谱法检测分析25-羟维生素D,结果如下表4-6所示:This comparative example uses traditional liquid chromatography mass spectrometry to detect and analyze 25-hydroxyvitamin D. The results are shown in Table 4-6 below:
表4精密度的计算结果Table 4 Calculation results of precision
Figure PCTCN2021077973-appb-000003
Figure PCTCN2021077973-appb-000003
表5线性范围的计算结果Table 5 Calculation results of linear range
Figure PCTCN2021077973-appb-000004
Figure PCTCN2021077973-appb-000004
表6 25-羟维生素D的回收率Table 6 Recovery rate of 25-hydroxyvitamin D
分析物Analyte 平均(%)average(%) 95%置信区间95% confidence interval
25-羟维生素D225-hydroxy vitamin D2 9191 85-10085-100
25-羟维生素D325-hydroxyvitamin D3 8888 74-10074-100
综上所述,本发明提供的方法可以将25-(OH)D特异地从复杂生物样本中富集并纯化,同时实现25-(OH)D2和25-(OH)D3的分别精准检测,相对于传统方法,具有高特异性、高通量和定量精准等特点。In summary, the method provided by the present invention can specifically enrich and purify 25-(OH)D from complex biological samples, while simultaneously achieving precise detection of 25-(OH)D2 and 25-(OH)D3, respectively. Compared with traditional methods, it has the characteristics of high specificity, high throughput and accurate quantification.
以上对本发明的具体实施例进行了详细描述,但其只是作为范例,本发明并不限制于以上描述的具体实施例。对于本领域技术人员而言,任何对本发明进行的等同修改和替代也都在本发明的范畴之中。因此,在不脱离本发明的精神和范围下所作的均等变换和修改,都应涵盖在本发明的范围内。The specific embodiments of the present invention are described in detail above, but they are only examples, and the present invention is not limited to the specific embodiments described above. For those skilled in the art, any equivalent modifications and substitutions made to the present invention are also within the scope of the present invention. Therefore, all equivalent changes and modifications made without departing from the spirit and scope of the present invention should all fall within the scope of the present invention.

Claims (10)

  1. 一种基于免疫纯化结合质谱检测的25-羟维生素D分析方法,其特征在于,包括如下步骤:A 25-hydroxyvitamin D analysis method based on immunopurification combined with mass spectrometry detection is characterized in that it comprises the following steps:
    步骤一,制备生物素标记抗体:Step one, prepare biotin-labeled antibody:
    (1)用pH为8.1的磷酸盐缓冲液透析25-羟维生素D抗体16-24h,将透析后的抗体加入生物素,然后进一步加入磷酸盐缓冲液对抗体进行稀释,并混匀得到混合液;(1) Dialyze the 25-hydroxyvitamin D antibody with pH 8.1 phosphate buffer for 16-24 hours, add biotin to the dialyzed antibody, and then further add phosphate buffer to dilute the antibody, and mix to obtain a mixed solution ;
    (2)将混合液置于恒温培养箱中,静置反应120±10min得到生物素标记抗体;(2) Place the mixed solution in a constant temperature incubator and let it stand for 120±10 minutes to obtain a biotin-labeled antibody;
    (3)使用pH为7.4的磷酸盐缓冲液透析所述生物素化抗体16-24h;(3) Dialysis the biotinylated antibody with a phosphate buffer with a pH of 7.4 for 16-24 hours;
    步骤二,制备生物素标记抗体包被的磁珠:Step two, prepare magnetic beads coated with biotin-labeled antibody:
    (1)将亲和素磁珠用磁珠清洗液清洗,然后再用结合缓冲液复溶;(1) Wash the avidin magnetic beads with magnetic bead cleaning solution, and then reconstitute it with binding buffer;
    (2)将溶解后的所述亲和素磁珠和步骤一制备的所述生物素标记抗体混合,然后置于恒温振荡箱振荡反应得到生物素标记抗体包被的磁珠;(2) Mix the dissolved avidin magnetic beads with the biotin-labeled antibody prepared in step 1, and then place the avidin-labeled antibody-coated magnetic beads in a constant temperature shaking box for shaking reaction;
    (3)反应后,用磁珠清洗液清洗所述磁珠,并稀释,2-8℃保存待用;(3) After the reaction, wash the magnetic beads with a magnetic bead cleaning solution, dilute, and store at 2-8°C until use;
    步骤三,富集纯化样品:将样品加入同位素内标溶液、所述生物素标记抗体包被的磁珠,室温搅拌孵育,用超纯水重复洗涤至少3次;洗涤后的磁珠采用有机溶剂进行2次洗脱,并收集洗脱液;Step three, enrich and purify the sample: add the sample to the isotope internal standard solution, the magnetic beads coated with the biotin-labeled antibody, stir and incubate at room temperature, and repeat the washing with ultrapure water for at least 3 times; the washed magnetic beads use an organic solvent Perform two elutions and collect the eluate;
    步骤四,质谱检测:步骤三得到的所述洗脱液吹干后复溶或直接转移至微孔板中,上液相质谱仪器检测。Step four, mass spectrometry detection: the eluent obtained in step three is dried and reconstituted or directly transferred to a microplate, and detected by a liquid-phase mass spectrometer.
  2. 根据权利要求1所述的25-羟维生素D分析方法,其特征在于,步骤一中所述透析是在4℃或室温条件下进行的,持续16-24h。The 25-hydroxyvitamin D analysis method of claim 1, wherein the dialysis in step 1 is performed at 4°C or room temperature for 16-24 hours.
  3. 根据权利要求1所述的25-羟维生素D分析方法,其特征在于,所述步骤一中的所述恒温箱温度设置为25±1℃。The 25-hydroxyvitamin D analysis method according to claim 1, wherein the temperature of the incubator in the step one is set to 25±1°C.
  4. 根据权利要求1所述的25-羟维生素D分析方法,其特征在于,所述步骤一中所述抗体和生物素的重量比为10-20:1。The 25-hydroxyvitamin D analysis method of claim 1, wherein the weight ratio of the antibody and biotin in the first step is 10-20:1.
  5. 根据权利要求1所述的25-羟维生素D分析方法,其特征在于,步骤二中所述磁珠清洗液的配制方法为:室温条件下,向一定体积的纯化水中加入1.212g的Tris、9.0g的氯化钠、0.4mL的HCl、0.2mL的Tween-20、5.0mL的20%NaN 3、0.5mL的Brij-35,混合均匀后检测pH值为8.3±0.2为合格,纯化水定容至1L。 The 25-hydroxyvitamin D analysis method according to claim 1, wherein the preparation method of the magnetic bead cleaning solution in step two is: adding 1.212g of Tris, 9.0 to a certain volume of purified water at room temperature. g of sodium chloride, 0.4mL of HCl, 0.2mL of Tween-20, 5.0mL of 20% NaN 3 , 0.5mL of Brij-35, after mixing evenly, the pH value is 8.3±0.2 as qualified, and the purified water is constant volume To 1L.
  6. 根据权利要求1所述的25-羟维生素D分析方法,其特征在于,步骤二中所述结合缓冲液的配制方法为:室温条件下,向一定体积的纯化水中加入6.06g的Tris、9.0g的氯化钠和3.84mL的HCl,至少搅拌5min至完全溶解,然后加入1.0mL的Tween-20和5mL 20%NaN 3,最后缓慢加入10.0g的牛血清白蛋白,至少搅拌10min至完全溶解;待所有成分完全溶解后,用pH计测pH值在7.2±0.1为合格,纯化水定容至1L。 The 25-hydroxyvitamin D analysis method according to claim 1, wherein the method for preparing the binding buffer in step two is: adding 6.06g of Tris, 9.0g to a certain volume of purified water at room temperature sodium chloride and 3.84mL of HCl, stirred 5min at least until complete dissolution, followed by addition of 1.0mL of Tween-20 and 5mL 20% NaN 3, and finally slowly added 10.0g of bovine serum albumin, at least 10min stirring until completely dissolved; After all the ingredients are completely dissolved, use a pH meter to measure the pH value of 7.2±0.1 as qualified, and dilute the purified water to 1L.
  7. 根据权利要求1所述的25-羟维生素D分析方法,其特征在于,步骤二清洗时,所述磁珠与磁珠清洗液的体积比小于或等于1:2。The 25-hydroxyvitamin D analysis method according to claim 1, characterized in that, during the cleaning step 2, the volume ratio of the magnetic beads to the magnetic bead cleaning solution is less than or equal to 1:2.
  8. 根据权利要求1所述的25-羟维生素D分析方法,其特征在于,所述同位素内标溶液为 2H 3-25-羟基维生素D2或 2H 3-25-羟基维生素D3。 The 25-hydroxyvitamin D analysis method of claim 1, wherein the isotope internal standard solution is 2 H 3 -25-hydroxy vitamin D2 or 2 H 3 -25-hydroxy vitamin D3.
  9. 根据权利要求1所述的25-羟维生素D分析方法,其特征在于,步骤三中洗脱采用的所述有机溶剂为75%乙腈,其含0.1%甲酸。The 25-hydroxyvitamin D analysis method according to claim 1, wherein the organic solvent used for elution in step 3 is 75% acetonitrile, which contains 0.1% formic acid.
  10. 根据权利要求1所述的25-羟维生素D分析方法,其特征在于,步骤三中振荡反应的参数为:在温度为37±2℃,振荡速度为100rmp/min的条件下反应16-24h。The 25-hydroxyvitamin D analysis method according to claim 1, characterized in that the parameters of the shaking reaction in step 3 are: reacting at a temperature of 37±2° C. and an shaking speed of 100 rmp/min for 16-24 hours.
PCT/CN2021/077973 2020-02-27 2021-02-25 25-hydroxyvitamin d analysis method based on immunopurification in combination with mass spectrometric detection WO2021170053A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010125706.6 2020-02-27
CN202010125706.6A CN111366646B (en) 2020-02-27 2020-02-27 25-hydroxyvitamin D analysis method based on immune purification and mass spectrometry detection

Publications (1)

Publication Number Publication Date
WO2021170053A1 true WO2021170053A1 (en) 2021-09-02

Family

ID=71208272

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/077973 WO2021170053A1 (en) 2020-02-27 2021-02-25 25-hydroxyvitamin d analysis method based on immunopurification in combination with mass spectrometric detection

Country Status (2)

Country Link
CN (1) CN111366646B (en)
WO (1) WO2021170053A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114371065A (en) * 2021-12-28 2022-04-19 上海固容生物科技有限公司 Method for processing liquid biopsy sample of biological sample (magnetic bead separation method) and application thereof
CN114544836A (en) * 2022-03-11 2022-05-27 天津国科医工科技发展有限公司 Pretreatment method and detection method for detecting trace estrogen, 17-hydroxypregnanolone, aldosterone and dehydroepiandrosterone sulfate
CN116203256A (en) * 2023-03-06 2023-06-02 深圳泰乐德医疗有限公司 Kit for detecting vitamin B6 and detection method thereof

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111366646B (en) * 2020-02-27 2022-09-23 苏州新波生物技术有限公司 25-hydroxyvitamin D analysis method based on immune purification and mass spectrometry detection
CN111879876A (en) * 2020-08-07 2020-11-03 苏州新波生物技术有限公司 Rapid and sensitive analysis method for 25 hydroxyvitamin D based on immune mass spectrometry technology
CN113063871B (en) * 2021-03-24 2022-12-27 杭州佰辰医疗器械有限公司 Metabolic small molecule detection method and detection system
CN114487209A (en) * 2022-03-08 2022-05-13 天津国科医工科技发展有限公司 Liquid chromatography tandem mass spectrometry detection method of fat-soluble vitamins based on magnetic solid phase extraction
CN115078559B (en) * 2022-03-24 2024-05-28 杭州佰辰医学检验所有限公司 Vitamin D rapid detection method based on single quadrupole mass spectrometry, kit and application
CN116500281B (en) * 2023-06-26 2023-11-07 天津赛飞乐生物技术有限公司 1, 25-dihydroxyvitamin D detection material, preparation method thereof and 1, 25-dihydroxyvitamin D detection method

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007055283A1 (en) * 2005-11-10 2007-05-18 Jsr Corporation Method for proteomics analysis of nuclear receptor protein complex
EP2372365A1 (en) * 2010-04-01 2011-10-05 Future Diagnostics B.V. Direct immunoassay for vitamin D
US20140033805A1 (en) * 2012-07-13 2014-02-06 Waters Technologies Corporation Methods of extracting fat soluble vitamins
CA2978570A1 (en) * 2015-03-03 2016-09-09 Quest Diagnostics Investments Llc Methods for quantitation of insulin levels by mass spectrometry
CN106574934A (en) * 2014-07-07 2017-04-19 株式会社日立高新技术 Analysis device and analysis method
CN110702928A (en) * 2019-09-25 2020-01-17 迪瑞医疗科技股份有限公司 Stable 25-hydroxy vitamin D chemiluminescence immunoassay kit
CN111366646A (en) * 2020-02-27 2020-07-03 苏州新波生物技术有限公司 25-hydroxyvitamin D analysis method based on immune purification and mass spectrometry detection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9052308B2 (en) * 2011-01-07 2015-06-09 The General Hospital Corporation Assays and methods of treatment relating to vitamin D insufficiency
US20140141986A1 (en) * 2011-02-22 2014-05-22 David Spetzler Circulating biomarkers
CN105929166A (en) * 2016-04-20 2016-09-07 北京中航赛维生物科技有限公司 Magnetic particle-based quantitative chemiluminescent assay kit for anti-LKM-1 antibody IgG, and preparation and detection methods thereof
CN109188001A (en) * 2018-08-13 2019-01-11 深圳天辰医疗科技有限公司 A kind of detection reagent of 25-hydroxy-vitamin D and preparation method thereof and kit

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007055283A1 (en) * 2005-11-10 2007-05-18 Jsr Corporation Method for proteomics analysis of nuclear receptor protein complex
EP2372365A1 (en) * 2010-04-01 2011-10-05 Future Diagnostics B.V. Direct immunoassay for vitamin D
US20140033805A1 (en) * 2012-07-13 2014-02-06 Waters Technologies Corporation Methods of extracting fat soluble vitamins
CN106574934A (en) * 2014-07-07 2017-04-19 株式会社日立高新技术 Analysis device and analysis method
CA2978570A1 (en) * 2015-03-03 2016-09-09 Quest Diagnostics Investments Llc Methods for quantitation of insulin levels by mass spectrometry
CN110702928A (en) * 2019-09-25 2020-01-17 迪瑞医疗科技股份有限公司 Stable 25-hydroxy vitamin D chemiluminescence immunoassay kit
CN111366646A (en) * 2020-02-27 2020-07-03 苏州新波生物技术有限公司 25-hydroxyvitamin D analysis method based on immune purification and mass spectrometry detection

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LEI FANG, LI CHENG-LONG, ZHANG XIN, ZHOU SHUANG, WANG DAN, WU YONG NING: "Rapid determination of mycotoxins in wheat by immune magnetic beads affinity purification with ultra performance liquid chromatography-tandem mass spectrometry", JOURNAL OF FOOD SAFETY & QUALITY, BEIJING ELECTRONICS HOLDING CO. LTD, CN, vol. 7, no. 3, 1 March 2016 (2016-03-01), CN, pages 1252 - 1260, XP055841221, ISSN: 2095-0381 *
MIREIA FERN�NDEZ OCA�A, IAN T. JAMES, MUSARAT KABIR, CHRISTOPHER GRACE, GUOJUN YUAN, STEVEN W. MARTIN, HENDRIK NEUBERT: "Clinical Pharmacokinetic Assessment of an Anti-MAdCAM Monoclonal Antibody Therapeutic by LC-MS/MS", ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, vol. 84, no. 14, 17 July 2012 (2012-07-17), pages 5959 - 5967, XP055066256, ISSN: 00032700, DOI: 10.1021/ac300600f *
XU YANG, MEHL JOHN T., BAKHTIAR RAY, WOOLF ERIC J.: "Immunoaffinity Purification Using Anti-PEG Antibody Followed by Two-Dimensional Liquid Chromatography/Tandem Mass Spectrometry for the Quantification of a PEGylated Therapeutic Peptide in Human Plasma", ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 82, no. 16, 15 August 2010 (2010-08-15), US, pages 6877 - 6886, XP055841212, ISSN: 0003-2700, DOI: 10.1021/ac1009832 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114371065A (en) * 2021-12-28 2022-04-19 上海固容生物科技有限公司 Method for processing liquid biopsy sample of biological sample (magnetic bead separation method) and application thereof
CN114544836A (en) * 2022-03-11 2022-05-27 天津国科医工科技发展有限公司 Pretreatment method and detection method for detecting trace estrogen, 17-hydroxypregnanolone, aldosterone and dehydroepiandrosterone sulfate
CN116203256A (en) * 2023-03-06 2023-06-02 深圳泰乐德医疗有限公司 Kit for detecting vitamin B6 and detection method thereof

Also Published As

Publication number Publication date
CN111366646A (en) 2020-07-03
CN111366646B (en) 2022-09-23

Similar Documents

Publication Publication Date Title
WO2021170053A1 (en) 25-hydroxyvitamin d analysis method based on immunopurification in combination with mass spectrometric detection
US7935921B2 (en) Methods and systems for the quantitative analysis of biomarkers
JP6571666B2 (en) Solution for dissociating vitamin D from vitamin D binding protein, its associated detection method and use
CN110736835B (en) Kit for measuring immunosuppressant cyclosporine A in whole blood by high-sensitivity latex-enhanced turbidimetric immunoassay
CN114166966B (en) Method for determining pro-SFTPB value in serum
CN110736836B (en) Kit for measuring immunosuppressant tacrolimus in whole blood by high-sensitivity latex-enhanced turbidimetric immunoassay
CN111879876A (en) Rapid and sensitive analysis method for 25 hydroxyvitamin D based on immune mass spectrometry technology
US20160077092A1 (en) Methods for analysis of free and autoantibody-bound biomarkers and associated compositions, devices, and systems
US11442073B2 (en) Methods and systems for measuring serotonin in a sample
CN111398490A (en) Kit for detecting free triiodothyronine and free thyroxine by mass spectrometry
US20180335431A1 (en) Novel multiplex assays to diagnose or evaluate diseases or disorders in mammals
CN109704954B (en) 3- (3-hydroxyphenyl) -3-hydroxypropionic acid derivative, homogeneous enzyme immunoassay reagent and preparation method thereof
JP2022514379A (en) Methods for Measuring Testosterone Using LC-MSMS
US20070166766A1 (en) Method and apparatus for mass spectrometric immunoassay analysis of specific biological fluid proteins
Yu et al. An automated magnetic bead extraction method for measuring plasma metanephrines and 3-methoxytyramine using liquid chromatography tandem mass spectrometry
CN112485418B (en) Release agent for detecting vitamin B12 content of human body and application thereof
CN116953248A (en) Kit for measuring beta-amyloid (1-42) in human serum/plasma by magnetic particle chemiluminescence method
Wang et al. Glycan reductive amino acid coded affinity tagging (GRACAT) for highly specific analysis of N-glycome by mass spectrometry
CN116338163A (en) Method for quantitatively detecting CD3/GPRC5D bispecific antibody by one-step method
Ren et al. Development of a high‐throughput, indirect antibody immobilization format chemiluminescence enzyme immunoassay (CLEIA) for the determination of progesterone in human serum
CN114397379A (en) Method for determining concentration of ornidazole in blood plasma by liquid chromatography-mass spectrometry
CN108303553B (en) Method for determining medroxyprogesterone acetate content based on magnetic microsphere chemiluminescence method, kit and application
Lin et al. A parallel processing solid phase extraction protocol for the determination of whole blood folate
CN111505273A (en) Non-competitive chemiluminescence immunoassay kit for digoxin and application thereof
CN117606896B (en) Method for detecting concentration of GNP in human serum sample

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21760580

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21760580

Country of ref document: EP

Kind code of ref document: A1